Publicacións nas que colabora con Santiago Rodríguez-Segade Villamarín (36)

2011

  1. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity

    Journal of Child Neurology

2010

  1. Levels of leptin, insulin, IGF-I, IGFBP-3, IL-6 and IL-8 in sera of patients with muscular dystrophy and mitochondrial encephalomyopathy

    Journal of Pediatric Neurology, Vol. 8, Núm. 4, pp. 375-379

2008

  1. Therapeutic criteria in communicating childhood hydrocephalus

    Journal of Neurosurgical Sciences, Vol. 52, Núm. 1, pp. 17-21

2007

  1. Evolution of Subclinical Hypothyroidism in Children Treated With Antiepileptic Drugs

    Pediatric Neurology, Vol. 37, Núm. 6, pp. 426-430

2006

  1. Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital

    Journal of Child Neurology, Vol. 21, Núm. 1, pp. 48-53

  2. Treatment of Mitochondrial Encephalomyopathies With a Xanthine Oxidase Inhibitor

    Pediatric Neurology, Vol. 35, Núm. 5, pp. 318-322

2004

  1. A standardised protocol for the quantification of lactate dehydrogenase activity in saliva

    Archives of Oral Biology, Vol. 49, Núm. 1, pp. 23-27

2003

  1. Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis

    Brain and Development, Vol. 25, Núm. 2, pp. 102-106

2001

  1. Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis

    Journal of Child Neurology, Vol. 16, Núm. 9, pp. 704-706

2000

  1. Cerebrospinal fluid purine metabolite and neuron-specific enolase concentrations after febrile seizures

    Brain and Development, Vol. 22, Núm. 7, pp. 427-431

1999

  1. Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children

    Brain and Development, Vol. 21, Núm. 1, pp. 16-19

1998

  1. Aciduria 3 -hidroxi-3 -metilglutârica y sîndrome Reye-like récurrente

    Revista de Neurologia, Vol. 26, Núm. 154, pp. 911-914

  2. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital

    Journal of Child Neurology, Vol. 13, Núm. 11, pp. 546-549

1997

  1. A two-base deletion in exon 6 of the 3-hydroxy-3-methylglutaryl coenzyme A lyase (HL) gene producing the skipping of exons 5 and 6 determines 3- hydroxy-3-methylglutaric aciduria

    Journal of Lipid Research, Vol. 38, Núm. 11, pp. 2303-2313

1996

  1. Cerebrospinal fluid purine metabolites after complex febrile convulsions

    Child's Nervous System, Vol. 12, Núm. 6, pp. 315-317

1995

  1. Cerebrospinal Fluid Purine Metabolites and Pyrimidine Bases After Brief Febrile Convulsions

    Epilepsia, Vol. 36, Núm. 5, pp. 471-474

  2. Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy

    Clinica Chimica Acta, Vol. 243, Núm. 2, pp. 151-164

1994

  1. Purine nucleotides degradation in the cerebrospinal fluid of newborns with sepsis

    International Pediatrics, Vol. 9, Núm. 1, pp. 63-64

1993

  1. Concentrations of nucleotides, nucleosides, purine bases and urate in cerebrospinal fluid of children with meningitis

    Acta Pædiatrica, Vol. 82, Núm. 11, pp. 849-852

  2. Indicators of hypoxia in cerebrospinal fluid of hydrocephalic children with suspected shunt malfunction

    Child's Nervous System, Vol. 9, Núm. 5, pp. 275-277